Answers are grounded in this paper and cite their sources.
Vitiligo is an autoimmune disease characterized by depigmented patches and macules. It is associated with many autoimmune diseases, the most common of which is thyroid diseases. The association between Interferon (IFN) therapy and vitiligo is rarely reported in the literature, despite its common usage in many diseases particularly hepatitis C viral infection (HCV). We report four cases of vitiligo that appeared after treating HCV with pegylated IFN.
No takes yet. Share an insight, caveat, or question.
Douhi et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: